Coxsackievirus B4 and type 1 diabetes pathogenesis: contribution of animal models
✍ Scribed by H. Jaïdane; F. Sané; J. Gharbi; M. Aouni; M. B. Romond; D. Hober
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 227 KB
- Volume
- 25
- Category
- Article
- ISSN
- 1520-7552
- DOI
- 10.1002/dmrr.995
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The study of the immunopathogenesis of IDDM in patients is hampered by several restrictions: 1. The onset of IDDM is relatively late in the natural history of the immune process since almost 80-90% of islets have to be destroyed before insulin deficiency is diagnosed. 2. The site of the immune pro
## Abstract The capsid protein VP4 was identified previously as the target of antibodies contained in plasma enhancing the coxscakievirus B4 (CV‐B4) E2‐induced production of IFN‐α by peripheral blood mononuclear cells (PBMCs). The sequence of VP4 recognized by these antibodies was investigated. Thi
## Abstract Several enterovirus serotypes should be considered as potentially diabetogenic. The capacity of an enterovirus to kill or impair the functions of human β‐cells can vary among the strains within a given serotype as shown previously for echovirus 9 and 30 (E‐30). The evolution of E‐30 has
Background Insulin and multiple other autoantigens have been implicated in the pathogenesis of autoimmune type 1 diabetes, but the origin of immunological self-reactivity specifically oriented against insulin-secreting islet b-cells remains obscure. The primary objective of the present study was to